相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Janus Kinases in Leukemia
Juuli Raivola et al.
CANCERS (2021)
The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications
Warren J. Leonard et al.
IMMUNITY (2019)
Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease
Gillian A. Durham et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Negative Regulation of Cytokine Signaling in Immunity
Akihiko Yoshimura et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Mechanisms and consequences of Jak-STAT signaling in the immune system
Alejandro V. Villarino et al.
NATURE IMMUNOLOGY (2017)
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
John J. O'Shea et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Adapter Protein Shc Regulates Janus Kinase 3 Phosphorylation
Jayshree Mishra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia
D. Bellanger et al.
LEUKEMIA (2014)
Biology and significance of the JAK/STAT signalling pathways
Hiu Kiu et al.
GROWTH FACTORS (2012)
Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors
Claude Haan et al.
CHEMISTRY & BIOLOGY (2011)
Phosphorylation of human Jak3 at tyrosines 904 and 939 positively regulates its activity
Hanyin Cheng et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Tracking STAT nuclear traffic
Nancy C. Reich et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Modulation of TLR4 signaling by a novel adaptor protein signal-transducing adaptor protein-2 in macrophages
Y Sekine et al.
JOURNAL OF IMMUNOLOGY (2006)
Intracellular signal transduction pathway proteins as targets for cancer therapy
AA Adjei et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Physical and functional interactions between STAP-2/BKS and STAT5
Y Sekine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-Bβ
JH Kurzer et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Determination of the transphosphorylation sites of Jak2 kinase
T Matsuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Jak3 and the pathogenesis of severe combined immunodeficiency
JJ O'Shea et al.
MOLECULAR IMMUNOLOGY (2004)
A new modality for immunosuppression: Targeting the JAK/STAT pathway
JJ O'Shea et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Is JAK3 a new drug target for immunomodulation-based therapies?
AC Papageorgiou et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
The Janus kinases (Jaks)
K Yamaoka et al.
GENOME BIOLOGY (2004)
Regulation of JAK-STAT signalling in the immune system
K Shuai et al.
NATURE REVIEWS IMMUNOLOGY (2003)
STATs: Transcriptional control and biological impact
DE Levy et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
CD45 controls interleukin-4-mediated IgE class switch recombination in human B cells through its function as a Janus kinase phosphatase
T Yamada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
SHP-1 expression in peripheral T cells from patients with Sezary syndrome and in the T cell line HUT-78:: implications in JAK3-meidated signaling
F León et al.
LEUKEMIA (2002)
The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3
PD Simoncic et al.
CURRENT BIOLOGY (2002)
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
J Irie-Sasaki et al.
NATURE (2001)
A small amphipathic α-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5
DM Wang et al.
EMBO JOURNAL (2000)
The Jak-STAT pathway
K Imada et al.
MOLECULAR IMMUNOLOGY (2000)
分享论文
